Events and Conferences

Meet Veristat in Boston at the Fierce Biotech Summit Conference | September 30 - October 1 in Boston, Massachusetts

Don't miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Barcelona, Thursday, October 24th at 12:10 pm CET:

Join Us for an Exclusive Conference on Product Launch Readiness in Europe - Lausanne, 24th October 2024, 17:00 CET

Veristat Announces Participation in the "Triangle Perspective on AI, ML, & the Future of Drug Development" Panel Discussion 

Meet the Veristat team at ASCO,  May 31st to June 4th in Chicago  

Meet the Veristat team at Booth #3, April 17th and 18th in Boston

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at 12pm ET, “Putting Science First in Rare Disease Studies”.  

Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024 

Meet the Veristat team at Booth #47, April 16th and 17th in Berlin. 

Thursday, April 4 | 11am EDT | 1 hour | Hosted by: Clinical Leader

In November 2022, FDA Oncology Center of Excellence (OCE) introduced Project FrontRunner to emphasize the need for new cancer drugs to be accessible to patients with early advanced metastatic cancer in an earlier clinical setting. The aim is to provide an alternative development pathway for faster approval of new treatments that does not follow the existing paradigm in which most treatments are developed for patients who have already received multiple prior lines of therapy or have failed available treatment options. Eligible development programs should have the potential to provide clinically meaningful treatment effects and/or have better safety profiles than the current “standards of care.”